Effect of Antigens or Therapeutic Agents on in Vitro Human Intestinal Organoids
NCT03256266 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 375
Last updated 2024-07-05
Summary
The study evaluates the effect of nutrient antigens or therapeutic agents on human small intestinal organoids.
Conditions
- Intestine Disease
Sponsors & Collaborators
-
University of Erlangen-Nürnberg Medical School
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-04-01
- Primary Completion
- 2025-07-31
- Completion
- 2025-07-31
Countries
- Germany
Study Locations
More Related Trials
-
Exploring the Effects of Caltrate Supplement on the Chronic Course of Crohn's Disease Patients With Vitamin D Deficiency
NCT04276636 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Is Local Injection of Mesenchymal Stem Cells After Endoscopic Dilation Safe and Does it Improve the Outcome of Intestinal Stricture in Patients With Crohn's Disease?
NCT06317818 ·Status: RECRUITING ·Phase: PHASE2
-
Safety and Activity of ORE1001 in Subjects With Ulcerative Colitis
NCT01039597 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Characterization of Disease Related Changes in Inflammatory Bowel Disease Using Fecal Metabolite Profiling
NCT01666717 ·Status: COMPLETED
-
Adherence to Exclusive Enteral Nutrition in Patients With Crohn's Disease
NCT04933214 ·Status: UNKNOWN
-
Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's Disease
NCT01233960 ·Status: COMPLETED ·Phase: PHASE3
-
Immunological Profiles in Inflammatory Bowel Disease
NCT03366090 ·Status: UNKNOWN
-
Mesenchymal Stem Cell Therapy for the Treatment of Severe or Refractory Inflammatory and/or Autoimmune Disorders
NCT01540292 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Exclusive Enteral Nutrition in Patients With Ileocaecal Crohn's Disease
NCT04921033 ·Status: RECRUITING ·Phase: PHASE3
-
Intestinal Stem Cells Characterization
NCT02874365 ·Status: COMPLETED ·Phase: NA
-
Blood and Stool Molecular Biomarkers Longitudinal Detection Study in Crohn's Disease (CD) Patients
NCT03566407 ·Status: TERMINATED ·Phase: NA
-
A Diagnostic Accuracy Study Testing Fecal Biomarkers In Comparison To Endoscopic Examination
NCT04849936 ·Status: UNKNOWN
-
A Study to Investigate the Efficacy of LT-02 in Patients With Mesalazine Refractory Ulcerative Colitis
NCT01011322 ·Status: UNKNOWN ·Phase: PHASE2
-
Clinical Study of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Moderate and Severe Crohn's Disease
NCT05262829 ·Status: UNKNOWN ·Phase: NA
-
Effect of Glutamine on Intestinal Permeability in Crohn's Disease
NCT00838149 ·Status: COMPLETED ·Phase: PHASE1
-
Adipose Mesenchymal Stem Cells (AMSC) for Treatment of Ulcerative Colitis
NCT03609905 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Comparison of MR Enteroclysis and MRI With Per Oral Contrast Using a 6 % Mannitol Solution.
NCT00204165 ·Status: UNKNOWN ·Phase: PHASE3
-
The Effect of Intestinal Microbiota Transplantation for Inflammatory Bowel Diseases
NCT03426683 ·Status: COMPLETED ·Phase: NA
-
Phase II Study of HMPL-004 in Subjects With Crohn's Disease
NCT00655733 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Safety and Efficacy of Telotristat Etiprate (LX1606) in Participants With Acute, Mild to Moderate Ulcerative Colitis
NCT01456052 ·Status: COMPLETED ·Phase: PHASE2
-
Autologous Stem Cell Transplant for Refractory Crohn's Disease
NCT02676622 ·Status: WITHDRAWN ·Phase: PHASE2
-
Localized Therapeutics for the Treatment of Gastrointestinal Disorders II
NCT02745678 ·Status: COMPLETED ·Phase: PHASE1
-
Role of the Chemical Environment in the Pathogenesis of Inflammatory Bowel Disease
NCT03376230 ·Status: TERMINATED
-
Autonomic and Cytokines Profiles of Patients With Ulcerative Proctitis
NCT03259659 ·Status: TERMINATED
-
Study of Factors and Mechanisms Influencing the Effects of Treatments in Crohn's Disease
NCT04135027 ·Status: UNKNOWN